A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β.
Level 5 - mechanism / opinion, no new human data
Animal research without human data (Oxford CEBM Level 5).
PubMed 22896675 · doi:10.1126/scitranslmed.3003748
What was done
In vivo two-photon imaging of small fluorescent tracers was used in animals to observe CSF entry and interstitial solute drainage pathways in the brain. The functional role of astrocytic water transport was evaluated by measuring CSF influx, interstitial solute clearance, and fluorescent-tagged amyloid beta removal in animals lacking the aquaporin-4 (Aqp4) gene compared to controls.
What was found
CSF entered the brain parenchyma along paravascular spaces surrounding penetrating arteries, while interstitial fluid drained along paravenous pathways. Animals lacking AQP4 exhibited slowed CSF influx and a ~70% reduction in interstitial solute clearance. Fluorescent-tagged amyloid beta cleared along this route, and Aqp4 gene deletion suppressed its clearance.
Why it matters
This study defines an astrocytic AQP4-dependent paravascular bulk flow clearance pathway for interstitial waste, providing a physiological mechanism for the clearance of amyloid beta and other proteins implicated in neurodegeneration.
Limits
The study was performed entirely in animal models, so findings cannot be directly assumed for human brain clearance. The abstract does not report exact sample sizes, animal species, variance metrics, or effect sizes for amyloid beta clearance specifically.
Cited by
- supports The glymphatic system, which acts as the brain's lymphatic drainage pathway, was verified by researchers in 2012.
- supports In 2012, neuroscientist Maiken Nedergaard discovered that the brain possesses a glia-mediated waste clearance system analogous to the lymphatic system.